As the global economy mends, the 2021 growth of Granulocyte Macrophage Colony Stimulating Factor will have significant change from previous year. According to our (LP Information) latest study, the global Granulocyte Macrophage Colony Stimulating Factor market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Granulocyte Macrophage Colony Stimulating Factor market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Granulocyte Macrophage Colony Stimulating Factor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Granulocyte Macrophage Colony Stimulating Factor market, reaching US$ million by the year 2028. As for the Europe Granulocyte Macrophage Colony Stimulating Factor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Granulocyte Macrophage Colony Stimulating Factor players cover Aduro BioTech Inc, Amgen Inc, BriaCell Therapeutics Corp, and Cold Genesys Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Granulocyte Macrophage Colony Stimulating Factor market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd